AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (707.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Infectious Diseases and the Use of Antimicrobials on Space Missions

Alice R. C. e Castro-Costa1, Rodrigo Siqueira-Batista1,2,3( ), Fabíola A. Alcântara1,3, Thaís Russomano3,4,5, Marlise A. dos Santos3,4, Isadora de C. e Silva2, Oswaldo M. Del Cima3,6
Department of Medicine and Nursing and Scientific Diving Unit, Universidade Federal de Viçosa, Viçosa, Brazil
School of Medicine, Faculdade Dinâmica do Vale do Piranga, Ponte Nova, Brazil
Space & Extreme Environment Research Center, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil
InnovaSpace, London, UK
Center for Aerospace Medicine Studies, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
Department of Physics and Scientific Diving Unit, Universidade Federal de Viçosa, Viçosa, MG, Brazil
Show Author Information

Abstract

Introduction

Exposure of the human body to the aerospace environment is capable of producing various physiological changes, which contributes to greater susceptibility of acquiring viral and/or bacterial infections.

Objective

To review studies on the use of antimicrobials in space to provide up-to-date information on the treatment of infectious diseases and contribute to the safety and well-being of astronauts on space voyages.

Method

Integrative literature review, using DeCS (https://decs.bvsalud.org/) and PubMed (https://pubmed.ncbi.nlm.nih.gov/).

Results and Discussion

Prolonged exposure to microgravity, radiation, and confinement can potentially affect the dynamics of interactions between microorganisms and Homo sapiens, causing astronauts to be more susceptible to infections in the aerospace environment. This context becomes more complex when we consider the greater possibility of drug-resistant bacterial strains emerging—due to radiation-related mutations—and the conditions that affect antimicrobial stability, especially excessive vibrations, a carbon dioxide-rich atmosphere, and variations in humidity temperature fluctuations. Additionally, physiological changes experienced by humans in the extraterrestrial environment—e.g., cardiovascular, respiratory, and renal—can alter the pharmacokinetics of antimicrobials.

Conclusion

Understanding the context in which astronauts are inserted, the risks involved, and how to avoid theses is essential for ensuring the safety and continuity of space missions with regards to diseases and the use of antimicrobials, which will allow humanity in space to have a “long and prosperous life”.

References

【1】
【1】
 
 
Space: Science & Technology
Article number: 0205

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Castro-Costa ARCe, Siqueira-Batista R, Alcântara FA, et al. Infectious Diseases and the Use of Antimicrobials on Space Missions. Space: Science & Technology, 2024, 4: 0205. https://doi.org/10.34133/space.0205

3

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 19 April 2024
Revised: 16 July 2024
Accepted: 06 September 2024
Published: 27 December 2024
© 2024 Alice R. C. e Castro-Costa et al. Exclusive licensee Beijing Institute of Technology Press. No claim to original U.S. Government Works.

Distributed under a Creative Commons Attribution License (CC BY 4.0).